GlassScriptPhysician profile
Richard H Dohn
NPI 1558384446
$2,392.79
in general payments reported to CMS, 2019-2025
18 companies · $807 in 2025
The $807 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $220 · 2021: $357 · 2022: $329 · 2023: $120 · 2024: $237 · 2025: $807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,163.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $643.30 | 2024-2025 | |
| Pfizer INC. | $498.27 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $330.22 | 2019-2021 | |
| Musculoskeletal Transplant Foundation INC. | $220.46 | 2022-2023 | |
| Boston Scientific Corporation | $126.05 | 2025 | General - Vascular Intervention |
| Sk Life Science, INC. | $114.73 | 2021-2024 | |
| Smith+Nephew, INC. | $109.76 | 2019-2024 | Grafix |
| Avanir Pharmaceuticals, INC. | $70.19 | 2019-2022 | |
| Organogenesis INC. | $61.60 | 2022-2025 | Cygnus Matrix, Affinity |
| Lilly USA, LLC | $31.67 | 2021-2024 | Mounjaro |
| Neurocrine Biosciences, INC. | $28.01 | 2024 | Ingrezza |
| Urgo Medical North America, LLC | $24.95 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Ipsen Biopharmaceuticals, INC | $23.75 | 2021 | |
| Osiris Therapeutics INC. | $23.24 | 2019 | |
| Acera Surgical, INC. | $22.55 | 2024 | Restrata Wound Matrix |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $22.34 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $21.49 | 2022 | |
| Integra Lifesciences Corporation | $20.21 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Dohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.